AT-20

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAT-20

Drug Alias NameAT-20

ClassificationBiologics

Mechanisms of ActionHIV p17 matrix protein inhibitors

TargetsHIV p17 matrix protein

Therapy Area/IndicationsHIV Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesMedestea

China Registration ClassN/A

Active CompaniesMedestea

Inactive CompaniesN/A

Active IndicationsHIV Infections

Inactive IndicationsN/A

ATC CodeN/A